Chemistry: molecular biology and microbiology – Treatment of micro-organisms or enzymes with electrical or... – Modification of viruses
Patent
1995-10-02
1998-11-17
Chambers, Jasemine C.
Chemistry: molecular biology and microbiology
Treatment of micro-organisms or enzymes with electrical or...
Modification of viruses
4353201, 435325, 4352351, 514 44, C12N 1500, C12N 1586
Patent
active
058375112
ABSTRACT:
The present invention provides replication-deficient non-group C adenoviral vectors. Also provided is a therapeutic method, particularly relating to gene therapy, vaccination, and the like, involving the use of such vectors incorporating a foreign nucleic acid.
REFERENCES:
patent: 4920209 (1990-04-01), Davis et al.
patent: 5543328 (1996-08-01), McClelland et al.
Kremer et al, Adenovirus and adeno-associated virus mediated gene transfer, British Medical Bulletin, vol. 51, No. 1, pp. 31-44, 1995.
Jolly, Douglas, Viral Vector systems for Gene Therapy, Cancer Gene Therapy, vol. 1, No. 1, pp. 51-64, 1994.
Berkner, K. L., Expression of Heterologous Sequences in Adenoviral Vectors, Current Topics in Microbiology and Immunology, vol. 158 pp. 39-66, Aug. 12, 1992.
Crystal, Ronald G., The Gene as the Drug, Nature Medicine, vol. 1, No. 1, pp. 15-17, Jan. 1995.
Chengalvala et al., Vaccine, 9, 485-490 (1991).
Chengalvala et al., J. Gen. Virol., 75, 125-131 (1994).
Horwitz, "Adenoviridae and Their Replication," in Fundamental Virology (Fields et al., eds., Raven Press Ltd., New York, NY, 2d ed., 1991), pp. 771-813.
Lindley et al., Gene, 138, 165-170 (1994).
Straus, "Adenovirus Infections in Humans," in Adenoviruses (Plenum Press, New York, NY 1984), pp. 451-496.
Orkin et al. Report and recommendation of the panel to assess the NIH investment in research on gene therapy. Distributed by the National Institutes of Health, Dec. 7, 1995.
Mastrangeli et al., J. Clinical Investigation, 91, 225-234 (1993).
Abrahamson Karil
Crystal Ronald G.
Falck-Pedersen Erik S.
Mastrangeli Andrea
Chambers Jasemine C.
Clark Deborah J. R.
Cornell Research Foundation Inc.
LandOfFree
Non-group C adenoviral vectors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Non-group C adenoviral vectors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-group C adenoviral vectors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-883319